Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
8.01
-0.04 (-0.50%)
At close: Mar 24, 2026, 4:00 PM EDT
7.96
-0.05 (-0.62%)
After-hours: Mar 24, 2026, 7:00 PM EDT
Emergent BioSolutions Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Emergent BioSolutions stock has a target of 12, which predicts a 49.81% increase from the current stock price of 8.01.
Price Target: $12 (+49.81%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Emergent BioSolutions is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $12 | Strong Buy | Maintains | $15 → $12 | +49.81% | Mar 9, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +87.27% | Dec 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +87.27% | Sep 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +87.27% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +87.27% | Mar 21, 2025 |
Financial Forecast
Revenue This Year
752.45M
from 742.90M
Increased by 1.29%
Revenue Next Year
678.72M
from 752.45M
Decreased by -9.80%
EPS This Year
0.53
from 0.93
Decreased by -43.53%
EPS Next Year
-0.97
from 0.53
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|
| High | 787.5M | 705.6M | ||
| Avg | 752.5M | 678.7M | ||
| Low | 725.2M | 658.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|
| High | 6.0% | -6.2% | ||
| Avg | 1.3% | -9.8% | ||
| Low | -2.4% | -12.5% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 0.55 | -1.01 |
| Avg | 0.53 | -0.97 |
| Low | 0.51 | -0.94 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | -41.3% | - |
| Avg | -43.5% | - |
| Low | -45.2% | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.